Maximum tolerated dose (MTD) and safety profile from phase I study of MT-3724 (CD20 targeted immunotoxin) in relapsed/refractory (R/R) non-Hodgkin B-cell lymphoma (NHL) Meeting Abstract


Authors: Fanale, M. A.; Park, S. I.; Valacer, D. J.; Higgins, J.; Sloan, J. M.; Younes, A.; Hamlin, P. A.
Abstract Title: Maximum tolerated dose (MTD) and safety profile from phase I study of MT-3724 (CD20 targeted immunotoxin) in relapsed/refractory (R/R) non-Hodgkin B-cell lymphoma (NHL)
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419705389
PROVIDER: wos
Notes: Meeting Abstract: 5212 -- Source: Wos